R&D

Eisai is committed to maintaining transparency of its relationships with healthcare professionals and healthcare organisations. Below are the details of all R&D payments made to healthcare professionals and healthcare organisations in all EFPIA countries.

For 2023, in all EFPIA countries, we have a total aggregated R&D spend of €27,235,862.82

2023 Methodological Note

EMEA-COR-24-00016 Date of Preparation: June 2024

For 2022, in all EFPIA countries, we have a total aggregated R&D spend of €16,262,113.49.

2022 Methodological Note

EMEA-COR-23-00029 Date of Preparation: August 2023

For 2021, in all EFPIA countries, we have a total aggregated R&D spend of €33,909,764.71

2021 Methodological Note

EMEA-COR-23-00005 Date of Preparation: January 2023